<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04851548</url>
  </required_header>
  <id_info>
    <org_study_id>FPFGRP/2021/566</org_study_id>
    <nct_id>NCT04851548</nct_id>
  </id_info>
  <brief_title>Evaluate the Effect of Hyaluronic Acid in the Treatment of Furcation Involvement</brief_title>
  <official_title>Evaluate the Effectiveness of Bioactive Hyaluronic Acid in the Treatment of Furcation Involvement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Riyadh Elm University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Riyadh Elm University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      the effect Hyaluronic Acid in the Treatment of Furcation Involvement&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The materials to be used in the study are the following:&#xD;
&#xD;
        -  Hyaluronic acid&#xD;
&#xD;
        -  Cone-beam computed tomography(CBCT) x-ray The patients with Grade II furcation will be&#xD;
           divided into two groups. Both groups will have the same number of patients and the same&#xD;
           procedure, such as the scaling root planning. However, the control group will use&#xD;
           hyaluronic acid and membrane. The placebo group, on the other hand, will use hyaluronic&#xD;
           acid without membrane and will use CBCT x-ray. The x-rays will be done at the beginning&#xD;
           of the treatment. Then, two monitoring processes will be done. The first monitor will be&#xD;
           done after three months. The data will be recorded. Then, after another three months,&#xD;
           the patients will undergo an x-ray check again, and the data will be recorded. The goal&#xD;
           is only to have the patients exposed to x-ray twice so they would not be compromised to&#xD;
           the high dose of radiation. The evaluation to be done for the 3-month interval will only&#xD;
           be clinical assessments.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 23, 2021</start_date>
  <completion_date type="Anticipated">September 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>test group use membrane and hyaluronic acid ,control group use membrane without hyaluronic acid</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>evaluate the regenerative effect of hyaluronic acid</measure>
    <time_frame>6 months</time_frame>
    <description>measurement of the bone gain after the treatment with hyaluronic acid in millimeters</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Furcation Defects</condition>
  <arm_group>
    <arm_group_label>Group A (control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preoperative cone-beam computed tomography (CBCT) scans N=9&#xD;
open flap debridement.&#xD;
use membrane without hyaluronic acid. (The first monitor will be done after three months. The data will be recorded. After another three months, the patients will undergo an x-ray check again, and the data will be registered. The goal is to have the patients exposed to x-ray twice not to be compromised to a high radiation dose. The evaluation to be done for the 3-month interval will only be clinical assessments|)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B (test)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preoperative cone-beam computed tomography (CBCT )scans N= 9&#xD;
open flap debridement.&#xD;
use membrane and 8% hyaluronic acid gel (The first monitor will be done after three months. The data will be recorded. After another three months, the patients will undergo an x-ray check again, and the data will be registered. The goal is to have the patients exposed to x-ray twice not to be compromised to a high radiation dose. The evaluation to be done for the 3-month interval will only be clinical assessments|).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hyaluronic acid</intervention_name>
    <description>after flap refection, the furcation area will be debrided then add hyaluronic acid 8% and cover it with a collagen membrane</description>
    <arm_group_label>Group A (control)</arm_group_label>
    <arm_group_label>Group B (test)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Selected teeth: Permanent first and second molars in the mandible.&#xD;
&#xD;
          2. Furcation dimension: Radiographic and clinical evidence of exhibiting defects due to&#xD;
             Grade II furcation with at least 2 millimeters probing depth horizontally and at least&#xD;
             5 millimeters probing depth circumferential.&#xD;
&#xD;
          3. Gender: both males and females.&#xD;
&#xD;
          4. Age range: between 18 and 55 years.&#xD;
&#xD;
          5. Health status: healthy patients non-systemic diseased except controlled diabetic.&#xD;
&#xD;
          6. Compliance: Patients will be willing and able to comply with adequate oral hygiene&#xD;
             protocols.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients that received periodontal regenerative therapy within the past 12 months.&#xD;
&#xD;
          2. Patients that are lactating.&#xD;
&#xD;
          3. Pregnant patients.&#xD;
&#xD;
          4. Smokers.&#xD;
&#xD;
          5. Patients with pulp infection.&#xD;
&#xD;
          6. Patients with trauma resulting from occlusion.&#xD;
&#xD;
          7. Patients with receding gum.&#xD;
&#xD;
          8. Patients with tooth mobility greater than grade II.&#xD;
&#xD;
          9. Patients that will not comply with the hygiene protocols in Phase I therapy.&#xD;
&#xD;
         10. Patients with potential illnesses that can influence the periodontal therapy outcomes.&#xD;
&#xD;
         11. Patients that are taking medications that can interfere with the healing outcomes of&#xD;
             the periodontal wound.&#xD;
&#xD;
         12. Patients allergic to any drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ahmed t gamal, clinical MD</last_name>
    <role>Study Director</role>
    <affiliation>Riyadh Elm University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ghady m alqhtani, BDS</last_name>
    <phone>00966541719298</phone>
    <email>ghadi.a.alqahtani2019@student.riyadh.edu.sa</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ahmed t gamal, clinical MD</last_name>
    <phone>00966564213932</phone>
    <email>ahmed.tawfig@riyadh.edu.sa</email>
  </overall_contact_backup>
  <reference>
    <citation>Kalra SH, Monga C, Kalra KH, Kalra SH. A roentgenographic assessment of regenerative efficacy of bioactive Gengigel(®) in conjunction with amnion membrane in grade II furcation defect. Contemp Clin Dent. 2015 Apr-Jun;6(2):277-80. doi: 10.4103/0976-237X.156068.</citation>
    <PMID>26097373</PMID>
  </reference>
  <reference>
    <citation>Sahayata VN, Bhavsar NV, Brahmbhatt NA. An evaluation of 0.2% hyaluronic acid gel (Gengigel ®) in the treatment of gingivitis: a clinical &amp; microbiological study. Oral Health Dent Manag. 2014 Sep;13(3):779-85.</citation>
    <PMID>25284557</PMID>
  </reference>
  <results_reference>
    <citation>Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975 Dec;25(4):229-35.</citation>
    <PMID>1058834</PMID>
  </results_reference>
  <results_reference>
    <citation>Gaurav Bakutra., et al. &quot;Prevalence, Extension and Severity Associated Risk Factors Associated with Furcation Involvement in an Adult Population. An Epidemiological Study</citation>
  </results_reference>
  <results_reference>
    <citation>Björn H, Halling A, Thyberg H. Radiographic assessment of marginal bone loss. Odontol Revy. 1969;20(2):165-79.</citation>
    <PMID>5259016</PMID>
  </results_reference>
  <results_reference>
    <citation>Carranza, F. A. &amp; Newman, M. G., 2018. Clinical Periodontology. USA: WB Saunders &amp; Co.</citation>
  </results_reference>
  <results_reference>
    <citation>Glickman, I. (1972). Clinical Periodontology: Prevention, Diagnosis, and Treatment of Periodontal Disease in the Practice of General Dentistry (4th ed.). Saunder.</citation>
  </results_reference>
  <results_reference>
    <citation>Pilloni A, Rojas MA. Furcation Involvement Classification: A Comprehensive Review and a New System Proposal. Dent J (Basel). 2018 Jul 23;6(3). pii: E34. doi: 10.3390/dj6030034. Review.</citation>
    <PMID>30041399</PMID>
  </results_reference>
  <results_reference>
    <citation>Sandhu GK, Khinda PK, Gill AS, Kalra HS. Surgical re-entry evaluation of regenerative efficacy of bioactive Gengigel(®) and platelet-rich fibrin in the treatment of grade II furcation: A novel approach. Contemp Clin Dent. 2015 Oct-Dec;6(4):570-3. doi: 10.4103/0976-237X.169855.</citation>
    <PMID>26681869</PMID>
  </results_reference>
  <results_reference>
    <citation>Sakpal TV. Sample size estimation in clinical trial. Perspect Clin Res. 2010 Apr;1(2):67-9.</citation>
    <PMID>21829786</PMID>
  </results_reference>
  <results_reference>
    <citation>https://doi.org/10.1902/jop.1959.30.1.7</citation>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>April 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Riyadh Elm University</investigator_affiliation>
    <investigator_full_name>Ghady Adnan Alqahtani</investigator_full_name>
    <investigator_title>periodontic resident</investigator_title>
  </responsible_party>
  <keyword>Hyaluronic Acid</keyword>
  <keyword>Furcation involvement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Furcation Defects</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

